| plan
| - Dr. Sewunet Admasu Belachew (PhD, MSc, BPharm) is a Postdoctoral Research Fellow in the FNCWR Program at the University of Queensland. He is involved in big, linked data analysis surrounding cancer, also being participated in the investigation of the risk of cardiovascular events and outcomes among Australians with a cancer diagnosis. He takes the lead and collaborates in undertaking various research projects (quantitative, qualitative and mixed-methods research), especially related to cancer and antimicrobial use and resistance surveillance as well as control.
Before pursuing his PhD, Dr. Belachew served as a lecturer, clinical preceptor, and mentor/supervisor at the University of Gondar in Ethiopia, where he taught courses such as pharmacotherapy, pharmacoepidemiology, and clinical pharmacy practice. In 2023, he completed his PhD at the University of Queensland. Since 2015, he has published over 43 peer-reviewed articles, with citation so far: 1287, H-index:22, i10-Index:28. His research has garnered attention from esteemed institutions and media outlets including the World Health Organization, the Centre for Infectious Disease Research and Policy (CIDRAP), Health Reporter, Medscape, Food and Agriculture Organization of the United Nations (FAO), the Conversation and Antimicrobial Resistance (AMR) Insights. underscoring the significance of his contributions to shaping policy and practice. In addition, one of his articles has been referred in two policy documents by World Health Organization. During his PhD study, he worked as causal acadmice at the University of Queensland and a research assistant at Menzies Health Institute-Centre for Applied Health Economics, Griffith University.
Dr. Belachew is an experienced medical and public health researcher (especially in antimicrobial resistance control and cancer research), academic and chief pharmacist, with over six years of experience. He has been recently nominated for the Faculty of Medicine Graduate of the Year Award at the University of Queensland due to his outstanding research output/track record. He has demonstrated ability in writing research grant, effective team work, research project management and supervising research students.
Dr. Belachew has been invited to speak in numerous scientific research meetings, including the Annual Symposium on Global Cancer Research organised by the National Cancer Institute of the USA (after winning prestigious travel grant), the International Congress of Antimicrobial Chemotherapy in Perth, Australia and the Australasian Epidemiological Association Annual and Early Career Researchers conference. He is a director for membership of the Pharmaco-economics and Outcomes Research (ISPOR) Ethiopian regional chapter and a board member of the Ethiopian Organisation for Cancer Prevention and Research. Moreover, he is also one of the few Ethiopian Young African Leadership Initiative (YALI) alumni.
- Dr. Sewunet Admasu Belachew (PhD, MSc, BPharm) is a Postdoctoral Research Fellow in the FNCWR Program at the University of Queensland. He is involved in big, linked data analysis surrounding cancer, also being participated in the investigation of the risk of cardiovascular events and outcomes among Australians with a cancer diagnosis. He takes the lead and collaborates in undertaking various research projects (quantitative, qualitative and mixed-methods research), especially related to cancer and antimicrobial use and resistance surveillance as well as control.
Before pursuing his PhD, Dr. Belachew served as a lecturer, clinical preceptor, and mentor/supervisor at the University of Gondar in Ethiopia, where he taught courses such as pharmacotherapy, pharmacoepidemiology, and clinical pharmacy practice. In 2023, he completed his PhD at the University of Queensland. Since 2015, he has published over 43 peer-reviewed articles, with citation so far: 1325, H-index:22, i10-Index:28. His research has garnered attention from esteemed institutions and media outlets including the World Health Organization, the Centre for Infectious Disease Research and Policy (CIDRAP), Health Reporter, Medscape, Food and Agriculture Organization of the United Nations (FAO), the Conversation and Antimicrobial Resistance (AMR) Insights. underscoring the significance of his contributions to shaping policy and practice. In addition, one of his articles has been referred in two policy documents by World Health Organization. During his PhD study, he worked as causal acadmice at the University of Queensland and a research assistant at Menzies Health Institute-Centre for Applied Health Economics, Griffith University.
Dr. Belachew is an experienced medical and public health researcher (especially in antimicrobial resistance control and cancer research), academic and chief pharmacist, with over six years of experience. He has been recently nominated for the Faculty of Medicine Graduate of the Year Award at the University of Queensland due to his outstanding research output/track record. He has demonstrated ability in writing research grant, effective team work, research project management and supervising research students.
Dr. Belachew has been invited to speak in numerous scientific research meetings, including the Annual Symposium on Global Cancer Research organised by the National Cancer Institute of the USA (after winning prestigious travel grant), the International Congress of Antimicrobial Chemotherapy in Perth, Australia and the Australasian Epidemiological Association Annual and Early Career Researchers conference. He is a director for membership of the Pharmaco-economics and Outcomes Research (ISPOR) Ethiopian regional chapter and a board member of the Ethiopian Organisation for Cancer Prevention and Research. Moreover, he is also one of the few Ethiopian Young African Leadership Initiative (YALI) alumni.
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
